Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
The 1982 revised criteria for the classification of systemic lupus erythematosus
1982 • 14,553 citations
Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIA
1973 • 6,904 citations
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
1990 • 1,618 citations
ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
1983 • 1,413 citations
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
1990 • 1,294 citations
Deficiency of protein C in congenital thrombotic disease.
1981 • 1,260 citations
Familial protein S deficiency is associated with recurrent thrombosis.
1984 • 614 citations
Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin
1991 • 583 citations
Plasma protein S deficiency in familial thrombotic disease
1984 • 516 citations
Properties of the factor Xa binding site on human platelets.
1978 • 443 citations
The Second International Anti-Cardiolipin Standardization Workshop/The Kingston Anti-Phospholipid Antibody Study (KAPS) Group
1990 • 420 citations
Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.
1980 • 367 citations
Serial propagation of human endothelial cells in vitro.
1981 • 348 citations
Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
1988 • 244 citations
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
1990 • 216 citations
Lupus Anticoagulants and Thrombosis
1985 • 197 citations
Effect of Lupus Anticoagulant on Antithrombogenic Properties of Endothelial Cells - Inhibition of Thrombomodulin-Dependent Protein C Activation
1988 • 194 citations
Immunological specificity and mechanism of action of IgG lupus anticoagulants
1987 • 193 citations
Purification and characterization of human coagulation factor V.
1981 • 187 citations
Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant
1989 • 178 citations
Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.
1992 • 175 citations
Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells
1982 • 149 citations
Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
1988 • 141 citations
An IgM Lupus Anticoagulant that Neutralizes the Enhancing Effect of Phospholipid on Purified Endothelial Thrombomodulin Activity-A Mechanism for Thrombosis
1986 • 130 citations
Distinguishing Plasma Lupus Anticoagulants from Anti-Factor Antibodies Using Hexagonal (II) Phase Phospholipids
1989 • 111 citations
Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo.
1990 • 93 citations
Isolation of human blood coagulation α-factor Xa by soybean trypsin inhibitor-Sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate
1989 • 85 citations
Thrombosis Associated with Antiphospholipid Antibodies Cannot Be Explained by Effects on Endothelial and Platelet Prostanoid Synthesis
1988 • 82 citations
Lupus anticoagulant: revival of an old phenomenon.
1985 • 76 citations
Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant
1989 • 73 citations
In Vitro Studies of Antiphospholipid Antibodies and Its Cofactor, β2-Glycoprotein I, Show Negligible Effects on Endothelial Cell Mediated Protein C Activation
1991 • 46 citations
Endothelial-Dependent Fibrinolysis in Subjects with the Lupus Anticoagulant and Thrombosis
1988 • 44 citations
Inhibition of human blood coagulation factor Xa by .alpha.2-macroglobulin
1987 • 33 citations
Inhibition of phospholipid and platelet‐dependent prothrombinase activity in the plasma of patients with lupus anticoagulants
1989 • 31 citations
The antiphospholipid antibody dilemma
1990 • 7 citations